Historical salary details - Ms. Dawn A. Svoronos, Independent Director, Acelyrin Inc
Ms. Dawn A. Svoronos is the Independent Director of Acelyrin Inc. They also hold 1 other positions in and Xenon Pharmaceuticals Inc.
Ms. Dawn A. Svoronos
Independent Director
-
Gross Remuneration
-
Current Company
Acelyrin Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Acelyrin Inc | Independent Director | - | - |
| 2024 | Xenon Pharmaceuticals Inc | Chairman of the Board | - | - |
| 2023 | Xenon Pharmaceuticals Inc | Lead Independent Director | 588.4 K | 26.5 % |
| 2023 | Acelyrin Inc | - | 376.7 K | -48.7 % |
| 2023 | Adverum Biotechnologies Inc | Independent Director | 106.7 K | 18.9 % |
| 2022 | Acelyrin Inc | Independent Director | 734.7 K | - |
| 2022 | Xenon Pharmaceuticals Inc | Lead Independent Director | 465.0 K | 138.4 % |
| 2022 | PTC Therapeutics Inc | Lead Independent Director | 464.0 K | -27.6 % |
| 2022 | Adverum Biotechnologies Inc | Independent Director | 89.7 K | -44.6 % |
| 2022 | PTC Therapeutics Inc | Independent Director | - | - |
| 2021 | PTC Therapeutics Inc | Independent Director | 640.7 K | 21.8 % |
| 2021 | Xenon Pharmaceuticals Inc | Lead Independent Director | 195.0 K | 51.7 % |
| 2021 | Adverum Biotechnologies Inc | Independent Director | 162.0 K | -61.7 % |
| 2020 | PTC Therapeutics Inc | Independent Director | 526.0 K | 57.3 % |
| 2020 | Adverum Biotechnologies Inc | Independent Director | 422.5 K | - |
| 2020 | Xenon Pharmaceuticals Inc | Independent Director | 128.6 K | -5.5 % |
| 2019 | PTC Therapeutics Inc | Independent Director | 334.4 K | 46.9 % |
| 2019 | Xenon Pharmaceuticals Inc | Independent Director | 136.1 K | 25.4 % |
| 2018 | PTC Therapeutics Inc | Independent Director | 227.5 K | 65.8 % |
| 2018 | Xenon Pharmaceuticals Inc | Independent Director | 108.5 K | 114.1 % |
| 2017 | PTC Therapeutics Inc | Independent Director | 137.3 K | 19.7 % |
| 2017 | Xenon Pharmaceuticals Inc | Independent Director | 50.7 K | 37.2 % |
| 2016 | PTC Therapeutics Inc | Independent Director | 114.6 K | - |
| 2016 | Xenon Pharmaceuticals Inc | Independent Director | 37.0 K | - |
| 2015 | PTC Therapeutics Inc | Independent Director | - | - |